Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perindopril in Hypertensive Children
NCT00202553Phase 2Completed
- Sponsor
- Servier
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of perindopril in hypertension (HTN), sponsored by Servier. Primary endpoint: Safety assessed from the patient's (parents) complaints and the clinical follow-up at 3 months. Started Jul 2003; status: completed.
02
Drugs
perindopril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00202553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00202553.